Tessa Therapeutics Completes US$126 Million Financing Led

Proceeds to fund clinical development of Tessa’s autologous (TT11) and allogeneic (TT11X) cell therapy programs Amy Schulman and Darren Carroll from...

Related Keywords

United States ,Singapore ,New York ,Boston ,Massachusetts ,San Francisco ,California ,American ,Temasek Charter ,Darren Carroll ,Amy Schulman ,Allogeneic Vsts ,Wilsonw Cheung ,Tessa Therapeutics Ltd ,Meeting Of The American Society Hematology ,Us Food Drug Administration ,Temasek ,European Medicine Agency ,Polaris Partners ,Heliconia Capital ,Managing Partners ,Annual Meeting ,American Society ,Tessa Therapeutics ,Host Disease ,European Medicine ,Epstein Barr Virus Specifict Cells ,Forward Looking ,Private Securities Litigation Reform Act ,Drug Administration ,